About Sciraise
Building the digital infrastructure for life science capital.
The science is moving faster than the capital that funds it. Sciraise exists to close that gap — connecting transformative biotech, medtech, and AI-driven healthcare companies with the global investors mandated to back them.
Our mission
Capital should move at the speed of science.
The next generation of medicines won't come from the labs that already have access to capital. They'll come from gene-editing pioneers in Stockholm, AI drug discovery teams in Cambridge, synthetic biology spinouts in Graz, and clinical-stage biotechs across emerging markets.
Sciraise is the institutional-grade platform built to surface, evaluate, and fund them — replacing the patchwork of email threads, spreadsheets, and gatekeepers that currently slow life science capital formation.
We are scientists, operators, and investors who have raised, deployed, and built across the biotech stack. We're building the platform we always wished existed.
Principles
What we believe.
Scientific rigor
Every workflow is designed around how scientists, founders, and investors actually evaluate breakthrough biology.
Institutional trust
Verified investor flows, audited data rooms, jurisdiction-aware compliance — credibility is not optional.
Global by design
Capital and science are global. Sciraise connects companies and investors across borders.
AI as infrastructure
Matching, scoring, and discovery powered by models trained on the structure of life science capital itself.
Get in touch.
Founders, investors, partners, press — we'd love to hear from you.